BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31115371)

  • 1. Effect of socio-economic status & proximity of patient residence to hospital on survival in childhood acute lymphoblastic leukaemia.
    Totadri S; Trehan A; Kaur A; Bansal D
    Indian J Med Res; 2019 Jan; 149(1):26-33. PubMed ID: 31115371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival from childhood acute lymphoblastic leukaemia in West Germany: does socio-demographic background matter?
    Erdmann F; Kaatsch P; Zeeb H; Roman E; Lightfoot T; Schüz J
    Eur J Cancer; 2014 May; 50(7):1345-53. PubMed ID: 24582913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: A step towards better focussed counselling.
    Alam A; Kumar A
    Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
    Jessop S; Ruhayel S; Sutton R; Youlden DR; Pearson G; Lu C; Milne S; Henderson MJ; Aitken JF; Kotecha RS; Revesz T
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28945. PubMed ID: 33565233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
    Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
    Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom.
    Lightfoot TJ; Johnston WT; Simpson J; Smith AG; Ansell P; Crouch S; Roman E; Kinsey SE
    Eur J Cancer; 2012 Jan; 48(2):263-9. PubMed ID: 22206862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
    Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out come of induction of remission in undernourished children with acute lymphoblastic leukaemia.
    Begum M; Jahan S; Tawfique M; Mannan MA
    Mymensingh Med J; 2012 Oct; 21(4):691-5. PubMed ID: 23134919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group.
    Cai J; Yu J; Zhu X; Hu S; Zhu Y; Jiang H; Li C; Fang Y; Liang C; Ju X; Tian X; Zhai X; Hao J; Hu Q; Wang N; Jiang H; Sun L; Li CK; Pan K; Yang M; Shen S; Cheng C; Ribeiro RC; Pui CH; Tang J;
    Arch Dis Child; 2019 Jun; 104(6):522-529. PubMed ID: 30705079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Antillón FG; Blanco JG; Valverde PD; Castellanos M; Garrido CP; Girón V; Letona TR; Osorio EJ; Borrayo DA; Mack RA; Melgar MA; Lorenzana R; Ribeiro RC; Metzger M; Conter V; Rossi E; Valsecchi MG
    Cancer; 2017 Feb; 123(3):436-448. PubMed ID: 27683100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D
    Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of childhood acute lymphoblastic leukemia treated in China.
    Tang Y; Xu X; Song H; Yang S; Shi S; Wei J
    Pediatr Blood Cancer; 2008 Sep; 51(3):380-6. PubMed ID: 18506765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of childhood acute lymphoblastic leukemia: experience in Chennai.
    Rajajee S; Desikulu MV; Pushpa V
    J Trop Pediatr; 1999 Dec; 45(6):367-70. PubMed ID: 10667009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
    Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
    Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukaemia: a study in Greece.
    Charalampopoulou A; Petridou E; Spyridopoulos T; Dessypris N; Oikonomou A; Athanasiadou-Piperopoulou F; Baka M; Kalmanti M; Polychronopoulou S; Trichopoulos D
    Eur J Cancer Prev; 2004 Oct; 13(5):397-401. PubMed ID: 15452452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Low-Birth Weight with Malnutrition in Children under Five Years in Bangladesh: Do Mother's Education, Socio-Economic Status, and Birth Interval Matter?
    Rahman MS; Howlader T; Masud MS; Rahman ML
    PLoS One; 2016; 11(6):e0157814. PubMed ID: 27355682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
    Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
    Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.